Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7176427 | 0.86 | — | — | |
| SCHEMBL8869611 | 0.82 | ALDH1A1 (0.37) | TSHRNFKB1CYP2C19 | |
| SCHEMBL8147768 | 0.80 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL114192 | 0.78 | NAAA (0.40) | — | |
| SCHEMBL4223230 | 0.74 | CETP (0.37) | — | |
| SCHEMBL4348704 | 0.74 | NAAA (0.49) | — | |
| SCHEMBL713338 | 0.72 | — | — | |
| SCHEMBL30795 | 0.71 | CYP2D6 (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL20113386 | 0.71 | CYP2D6 (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL2202765 | 0.71 | TSHR (0.30) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835329-B2 | Photostability; hindered amine light stabilizers | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-12-28 | — | — | US | disclosed |
| US-20040013619-A1 | Heteroaryl substituted hydroxyphenyltriazine uv-absorbers | CIBA SPECIALTY CHEMICALS CORP. | 2004-01-22 | — | — | US | disclosed |
| US-6271377-B1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013619-A1 | Heteroaryl substituted hydroxyphenyltriazine uv-absorbers | CBR1, CYP4Z1, CYP1A1 | TSHR 1844/4885NFKB1 1268/4885CYP2C19 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.